Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis - a double-blind, placebo-controlled study

A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery

(2011) N. Gubergrits et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis

(2011) James M Littlewood et al.   Expert Opinion On Drug Safety

Chronic pancreatitis

(2011) Joan M Braganza et al.   LANCET

Efficacy of a Novel Pancreatic Enzyme Product, EUR-1008 (Zenpep), in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis

(2011) Phillip P. Toskes et al.   PANCREAS

Pancrelipase Delayed-Release Capsules (CREON) for Exocrine Pancreatic Insufficiency due to Chronic Pancreatitis or Pancreatic Surgery: A Double-Blind Randomized Trial

(2010) David C Whitcomb et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis

(2010) Gavin R. Graff et al.   CLINICAL DRUG INVESTIGATION

Alcohol and Smoking as Risk Factors in an Epidemiology Study of Patients With Chronic Pancreatitis

(2010) Gregory A. Coté et al.   Clinical Gastroenterology and Hepatology

Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: A multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study

(2010) Gavin R. Graff et al.   CLINICAL THERAPEUTICS

Clinical Profile of Idiopathic Chronic Pancreatitis in North India

(2009) Deepak K. Bhasin et al.   Clinical Gastroenterology and Hepatology

Efficacy and safety of Creon® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis

(2009) Bruce C. Trapnell et al.   Journal of Cystic Fibrosis

Efficacy and Tolerability of Creon for Children in Infants and Toddlers With Pancreatic Exocrine Insufficiency Caused by Cystic Fibrosis

(2009) Carla Colombo et al.   PANCREAS

Genetic mechanisms underlying the pathogenesis of tropical calcific pancreatitis

(2009) Swapna Mahurkar et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Pancreatic enzyme replacement therapy for young cystic fibrosis patients

(2008) Anne Munck et al.   Journal of Cystic Fibrosis